P2.17-23 The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study
Eralp, Y., Ak, N., Yilmazbayhan, D., Özkan, B., Ferhatoğlu, F., Demirkazik, A., Sak, S. Dizbay, Dilege, Ş., Tanju, S., Toker, A., Bulutay, P., Firat, P., Mandel, N. Molinas, Kilickap, S., Onder, S., DVolume:
14
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2019.08.1934
Date:
October, 2019
File:
PDF, 518 KB
english, 2019